Esophageal Cancer News and Research RSS Feed - Esophageal Cancer News and Research

Esophageal Cancer is cancer that forms in tissues lining the esophagus (the muscular tube through which food passes from the throat to the stomach). Two types of esophageal cancer are squamous cell carcinoma (cancer that begins in flat cells lining the esophagus) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids).
Statins reduce patient's risk of developing Barrett's esophagus

Statins reduce patient's risk of developing Barrett's esophagus

Statins, a class of drugs commonly used to lower cholesterol levels, significantly reduce a patient's risk of developing Barrett's esophagus, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association. [More]
LINX Reflux Management System safe for patients suffering from GERD, shows new data

LINX Reflux Management System safe for patients suffering from GERD, shows new data

Torax Medical today announced the release of new data from two leading U.S. medical centers that further establishes the LINX Reflux Management System as a safe and effective procedure for patients suffering from gastroesophageal reflux disease (GERD). [More]
Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

Castle Biosciences reports study results from DecisionDx-EC multi-analyte test for esophageal cancer

Castle Biosciences Inc. today announced study results from its proprietary multi-analyte test DecisionDx-EC, which is designed to determine which patients with esophageal cancer are likely to respond or not respond to standard pre-surgical chemoradiation therapy. [More]
Effects of radiofrequency ablation and complete endoscopic resection are equal in dysplastic Barrett's esophagus

Effects of radiofrequency ablation and complete endoscopic resection are equal in dysplastic Barrett's esophagus

According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but adverse event rates are higher with complete endoscopic resection. [More]

Proteo Biotech, BDC sign deal to develop orphan medicinal product Tiprelestat

Proteo Inc. announced today that its German subsidiary, Proteo Biotech AG, has entered into an agreement with the US company Biotech Development Corp. (BDC). [More]
New biomarker shows promise in improving screening for esophageal cancer

New biomarker shows promise in improving screening for esophageal cancer

A new biomarker for esophageal cancer shows promise in improving screening for this deadly disease and its precursor, Barrett's esophagus. [More]
AGA announces recipients of its annual recognition awards 2014

AGA announces recipients of its annual recognition awards 2014

The American Gastroenterological Association (AGA) has announced the recipients of its annual recognition awards, given in honor of outstanding contributions and achievements in gastroenterology. [More]
Oral health: The gateway to your overall health

Oral health: The gateway to your overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your oral health and your overall health. [More]
AGA Research Foundation announces 2014 AGA Research Scholars

AGA Research Foundation announces 2014 AGA Research Scholars

The American Gastroenterological Association Research Foundation is pleased to announce the 2014 AGA Research Scholars. The AGA Research Scholar Awards program, launched in 1984, enables young investigators to develop independent and productive research careers in digestive diseases. This year, the AGA Research Scholar Awards fund an additional year allowing for three consecutive years of funding. [More]
Researchers examine interaction between alcohol and tobacco in risk of ESCC

Researchers examine interaction between alcohol and tobacco in risk of ESCC

The rate of developing esophageal squamous cell carcinoma (ESCC) nearly doubles in those who both smoke and drink compared to those who only smoke or drink, according to new research published in The American Journal of Gastroenterology. [More]
New fiber-optic device helps clinicians diagnose cancer at early-stage

New fiber-optic device helps clinicians diagnose cancer at early-stage

An engineering researcher at the University of Arkansas has developed an inexpensive, endoscopic microscope capable of producing high-resolution, sub-cellular images of tissue in real time. [More]
Study confirms safety of LINX Reflux Management System for GERD treatment

Study confirms safety of LINX Reflux Management System for GERD treatment

Millions of Americans suffer from Gastroesophageal Reflux Disease (GERD), a chronic, often progressive disease that can cause debilitating symptoms and lead to serious complications including pre-cancerous Barrett's esophagus and esophageal cancer. [More]
RPCI receives FDA approval to enroll patients in phase II clinical trial using I-PDT approach

RPCI receives FDA approval to enroll patients in phase II clinical trial using I-PDT approach

Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck. [More]
FDA grants PMA for Pinnacle's Optiguide DCYL700 Fiber Optic Diffuser Series flexible fiber

FDA grants PMA for Pinnacle's Optiguide DCYL700 Fiber Optic Diffuser Series flexible fiber

Concordia Healthcare Corp. announced today that its subsidiary Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, was granted U.S. Food and Drug Administration premarket supplemental approval (PMA) for its Optiguide DCYL700 Fiber Optic Diffuser Series flexible fiber. [More]
Long-term survivors after esophagectomy with gastric pull-up can enjoy good quality of life

Long-term survivors after esophagectomy with gastric pull-up can enjoy good quality of life

Long-term survivors after esophagectomy with gastric pull-up can enjoy a satisfying meal and good quality of life according to a new study from a team of researchers at the University of Southern California Keck School of Medicine, Los Angeles. [More]
Scientist receives AGA-GCF Research Scholar Award for research in gastric, esophageal cancer

Scientist receives AGA-GCF Research Scholar Award for research in gastric, esophageal cancer

The American Gastroenterological Association (AGA) Research Foundation and the Gastric Cancer Foundation (GCF) are pleased to announce that the first AGA-Gastric Cancer Foundation Research Scholar Award in Gastric and Esophageal Cancer will support Mohamed El-Zaatari, PhD, from University of Michigan, as he conducts research into the role of myeloid cells in the transition from chronic inflammation to gastric pre-neoplasia. [More]
Addition of confocal laser endomicroscopy to HDWLE improves diagnosis of Barrett's esophagus

Addition of confocal laser endomicroscopy to HDWLE improves diagnosis of Barrett's esophagus

New research shows that the addition of confocal laser endomicroscopy to high-definition white-light endoscopy enables improved real-time endoscopic diagnosis of Barrett's esophagus dysplasia (neoplastic tissue) by using targeted biopsies of abnormal mucosa to reduce unnecessary mucosal biopsies and potentially reduce costs. [More]
G. Alexander Patterson honored with 2014 Earl Bakken Scientific Achievement Award

G. Alexander Patterson honored with 2014 Earl Bakken Scientific Achievement Award

The Society of Thoracic Surgeons today awarded G. Alexander Patterson, MD with the 2014 Earl Bakken Scientific Achievement Award during the Society's 50th Annual Meeting. [More]
BUSM researcher receives grant for advancement in early detection, treatment of esophageal cancer

BUSM researcher receives grant for advancement in early detection, treatment of esophageal cancer

Tony Godfrey, PhD, associate chair of research in the department of surgery at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC), was recently awarded a two-year, $225,000 grant from the DeGregorio Family Foundation for Gastric and Esophageal Cancer Research & Education. [More]
Adenosine deaminase has potential to improve prognosis, diagnosis and treatment of ESCC

Adenosine deaminase has potential to improve prognosis, diagnosis and treatment of ESCC

Esophageal Squamous Cell Carcinoma (ESCC), the major histological form of esophageal cancer, is the leading cause of cancer death worldwide. Scientists from the National University of Singapore (NUS) have discovered a biomarker, called adenosine deaminase acting on RNA-1 (ADAR1), which has the potential to improve the diagnosis, prognosis and treatment of this disease. [More]